The core target and its receptor complex obtained by network pharmacology were first attached to the S protein by protein-protein docking, and then to the active ingredients connected with the core target by protein-small molecule docking, in order to simulate the process of drug intervention after COVID-19 invades the host cell receptor. This evidence concerns the gene PROS1 and COVID-19.